Atea Pharmaceuticals Investor Relations Material
Latest events
Q2 2024
Atea Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Atea Pharmaceuticals Inc
Access all reports
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics for patients suffering from viral infections. The company's pipeline includes several product candidates. Some of these medications have been demonstrated to have antibacterial activity against various bacterial pathogens and anti-inflammatory effects in animal studies.
Key slides for Atea Pharmaceuticals Inc
Q2 2024
Atea Pharmaceuticals Inc
14th Annual Jefferies London Healthcare Conference 2023
Atea Pharmaceuticals Inc
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
AVIR
Country
🇺🇸 United States